<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <recordedVotes />
    <actions>
      <item>
        <actionDate>2016-05-12</actionDate>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2016-05-11</actionDate>
        <committee />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <actionTime>18:49:40</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <links />
        <type>Floor</type>
        <actionCode>H38310</actionCode>
      </item>
      <item>
        <actionDate>2016-05-11</actionDate>
        <committee />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <actionTime>18:49:37</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2276-2277)</text>
        <links>
          <link>
            <name>H2276-2277</name>
            <url>https://www.congress.gov/congressional-record/volume-162/house-section/page/H2276-2277</url>
          </link>
        </links>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
      </item>
      <item>
        <actionDate>2016-05-11</actionDate>
        <committee />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <actionTime>18:49:37</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2276-2277)</text>
        <links>
          <link>
            <name>H2276-2277</name>
            <url>https://www.congress.gov/congressional-record/volume-162/house-section/page/H2276-2277</url>
          </link>
        </links>
        <type>Floor</type>
        <actionCode>8000</actionCode>
      </item>
      <item>
        <actionDate>2016-05-11</actionDate>
        <committee />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <actionTime>18:34:10</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4981.</text>
        <links>
          <link>
            <name>H.R. 4981</name>
            <url>https://www.congress.gov/bill/114th-congress/house-bill/4981</url>
          </link>
        </links>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
      </item>
      <item>
        <actionDate>2016-05-11</actionDate>
        <committee />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <actionTime>18:34:07</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H2276-2280)</text>
        <links>
          <link>
            <name>H2276-2280</name>
            <url>https://www.congress.gov/congressional-record/volume-162/house-section/page/H2276-2280</url>
          </link>
        </links>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
      </item>
      <item>
        <actionDate>2016-05-11</actionDate>
        <committee />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <actionTime>18:34:00</actionTime>
        <text>Mr. Guthrie moved to suspend the rules and pass the bill, as amended.</text>
        <links />
        <type>Floor</type>
        <actionCode>H30300</actionCode>
      </item>
      <item>
        <actionDate>2016-05-10</actionDate>
        <committee />
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Placed on the Union Calendar, Calendar No. 435.</text>
        <links />
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
      </item>
      <item>
        <actionDate>2016-05-10</actionDate>
        <committee>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Committee on the Judiciary discharged.</text>
        <links />
        <type>Discharge</type>
        <actionCode>H12300</actionCode>
      </item>
      <item>
        <actionDate>2016-05-10</actionDate>
        <committee>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Committee on the Judiciary discharged.</text>
        <links />
        <type>Committee</type>
        <actionCode>5500</actionCode>
      </item>
      <item>
        <actionDate>2016-05-10</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-561, Part I.</text>
        <links>
          <link>
            <name>H. Rept. 114-561</name>
            <url>https://www.congress.gov/congressional-report/114th-congress/house-report/561</url>
          </link>
        </links>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
      </item>
      <item>
        <actionDate>2016-05-10</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-561, Part I.</text>
        <links>
          <link>
            <name>H. Rept. 114-561</name>
            <url>https://www.congress.gov/congressional-report/114th-congress/house-report/561</url>
          </link>
        </links>
        <type>Committee</type>
        <actionCode>5000</actionCode>
      </item>
      <item>
        <actionDate>2016-04-27</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-27</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-26</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-25</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-22</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-20</actionDate>
        <committee>
          <systemCode>hsju08</systemCode>
          <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-18</actionDate>
        <committee>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to House Judiciary</text>
        <links />
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
      </item>
      <item>
        <actionDate>2016-04-18</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to House Energy and Commerce</text>
        <links />
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
      </item>
      <item>
        <actionDate>2016-04-18</actionDate>
        <committee />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <links />
        <type>IntroReferral</type>
        <actionCode>H11100-A</actionCode>
      </item>
      <item>
        <actionDate>2016-04-18</actionDate>
        <committee />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
        <links />
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
      </item>
      <item>
        <actionDate>2016-04-18</actionDate>
        <committee />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
        <links />
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
      </item>
      <actionTypeCounts>
        <motionMadeToSuspendTheRules>1</motionMadeToSuspendTheRules>
        <actionStageOverride>3</actionStageOverride>
        <reportedToHouse>1</reportedToHouse>
        <placeholderTextForH>3</placeholderTextForH>
        <motionToReconsiderResults>1</motionToReconsiderResults>
        <considerationByHouse>1</considerationByHouse>
        <houseCommitteeDischarged>1</houseCommitteeDischarged>
        <finalPassageUnderSuspensionOfTheRulesResults>1</finalPassageUnderSuspensionOfTheRulesResults>
        <committeeReportOfABill>1</committeeReportOfABill>
        <passedAgreedToInHouse>1</passedAgreedToInHouse>
        <referredToCommittee>1</referredToCommittee>
        <unionCalendarAssignment>1</unionCalendarAssignment>
        <introducedInTheHouse>1</introducedInTheHouse>
        <committeeDischarged>1</committeeDischarged>
        <billReferralsAggregate>1</billReferralsAggregate>
        <generalDebate>1</generalDebate>
        <introducedInHouse>1</introducedInHouse>
        <billReferrals>2</billReferrals>
      </actionTypeCounts>
      <actionByCounts>
        <senate>1</senate>
        <houseOfRepresentatives>22</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <cboCostEstimates>
      <item>
        <title>H.R. 4981, Opioid Use Disorder Treatment Expansion and Modernization Act</title>
        <pubDate>2016-05-31T21:55:46Z</pubDate>
        <url>https://www.cbo.gov/publication/51636</url>
      </item>
      <item>
        <title>H.R. 4981, Opioid Use Disorder Treatment Expansion and Modernization Act</title>
        <pubDate>2016-06-29T18:34:29Z</pubDate>
        <url>https://www.cbo.gov/publication/51739</url>
      </item>
    </cboCostEstimates>
    <cosponsors>
      <item>
        <sponsorshipDate>2016-04-18</sponsorshipDate>
        <bioguideId>T000469</bioguideId>
        <sponsorshipWithdrawnDate />
        <state>NY</state>
        <middleName />
        <identifiers>
          <lisID>1942</lisID>
          <gpoId>8082</gpoId>
          <bioguideId>T000469</bioguideId>
        </identifiers>
        <fullName>Rep. Tonko, Paul [D-NY-20]</fullName>
        <party>D</party>
        <firstName>Paul</firstName>
        <lastName>Tonko</lastName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <district>20</district>
      </item>
      <item>
        <sponsorshipDate>2016-04-28</sponsorshipDate>
        <bioguideId>R000592</bioguideId>
        <sponsorshipWithdrawnDate />
        <state>IN</state>
        <middleName />
        <identifiers>
          <lisID>2017</lisID>
          <bioguideId>R000592</bioguideId>
          <gpoId>7943</gpoId>
        </identifiers>
        <fullName>Rep. Rokita, Todd [R-IN-4]</fullName>
        <party>R</party>
        <firstName>Todd</firstName>
        <lastName>Rokita</lastName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <district>4</district>
      </item>
    </cosponsors>
    <introducedDate>2016-04-18</introducedDate>
    <latestAction>
      <actionDate>2016-05-12</actionDate>
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <links />
    </latestAction>
    <billNumber>4981</billNumber>
    <titles>
      <item>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <title>Opioid Use Disorder Treatment Expansion and Modernization Act</title>
        <chamberCode>H</chamberCode>
        <titleType>Short Titles as Passed House</titleType>
        <chamberName>House</chamberName>
      </item>
      <item>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <title>Opioid Use Disorder Treatment Expansion and Modernization Act</title>
        <chamberCode>H</chamberCode>
        <titleType>Short Titles as Reported to House</titleType>
        <chamberName>House</chamberName>
      </item>
      <item>
        <parentTitleType />
        <title>Opioid Use Disorder Treatment Expansion and Modernization Act</title>
        <chamberCode />
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <title>To amend the Controlled Substances Act to improve access to opioid use disorder treatment.</title>
        <chamberCode />
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <title>Opioid Use Disorder Treatment Expansion and Modernization Act</title>
        <chamberCode />
        <titleType>Display Title</titleType>
        <chamberName />
      </item>
    </titles>
    <amendments />
    <laws />
    <originChamber>House</originChamber>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. BUCSHON:H.R. 4981.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 3 of the United StatesConstitution[Page H1802]</pre>]]></constitutionalAuthorityStatementText>
    <calendarNumbers>
      <item>
        <number />
        <calendar>U00435</calendar>
      </item>
    </calendarNumbers>
    <title>Opioid Use Disorder Treatment Expansion and Modernization Act</title>
    <summaries>
      <billSummaries>
        <item>
          <text><![CDATA[<p><b>Opioid Use Disorder Treatment Expansion and Modernization Act</b></p> <p>This bill amends the Controlled Substances Act to revise the requirements for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.</p> <p>Currently, a practitioner must notify the Department of Health and Human Services (HHS) and certify that he or she is a qualifying physician (i.e., a state-licensed physician with certain expertise), has the capacity to refer patients for appropriate counseling and ancillary services, and will comply with a patient limit. The patient limit is how many patients the practitioner can treat under the office-based treatment program at one time.</p> <p>This legislation expands qualifying practitioners to include nurse practitioners and physician assistants who are licensed in a state, have expertise, and prescribe medications for opioid use disorder in collaboration with or under the supervision of a physician if required by state law. </p> <p>Additionally, it requires a qualifying practitioner to also certify that he or she will comply with reporting requirements and has the capacity to provide directly or by referral, or provide contact information of the nearest practitioner who can provide, all drugs approved by the Food and Drug Administration to treat opioid use disorder.</p> <p>Finally, the bill increases the patient limit for a qualifying physician who holds a specialized certification or completes specified training. A physician must additionally certify that he or she will maintain a diversion control plan and obtain written consent from each patient regarding available treatment options.</p> <p>HHS must update the treatment improvement protocol containing best practice guidelines for the treatment of opioid-dependent patients in office-based settings.</p> <p>HHS may recommend revoking or suspending the registration of a practitioner who fails to comply with the requirements of this Act.</p>]]></text>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2016-04-18T04:00:00Z</updateDate>
          <lastSummaryUpdateDate>2016-06-03T21:29:10Z</lastSummaryUpdateDate>
          <actionDate>2016-04-18</actionDate>
          <versionCode>00</versionCode>
          <name>Introduced in House</name>
        </item>
        <item>
          <text><![CDATA[<p><b>Opioid Use Disorder Treatment Expansion and Modernization Act</b></p> <p> (Sec. 3) This bill amends the Controlled Substances Act to revise the requirements for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program. </p> <p>Currently, a practitioner must notify the Department of Health and Human Services (HHS) and certify that he or she is a qualifying physician (i.e., a state-licensed physician with certain expertise), has the capacity to refer patients for appropriate counseling and ancillary services, and will comply with a patient limit. The patient limit is how many patients the practitioner can treat under the office-based treatment program at one time. </p> <p>This legislation expands qualifying practitioners to include nurse practitioners and physician assistants who are licensed in a state, have expertise (such as relevant training or expertise), and prescribe medications for opioid use disorder in collaboration with or under the supervision of a qualifying physician if state law requires physician oversight of prescribing authority. </p> <p>Additionally, it requires a qualifying practitioner to also certify that he or she will comply with reporting requirements and has the capacity to provide directly or by referral, or in another manner prescribed by HHS, all drugs approved by the Food and Drug Administration to treat opioid use disorder. </p> <p>Finally, the bill increases from 100 to 250 the maximum patient limit for a qualifying physician who holds a specialized certification or completes specified training. A physician must additionally certify that he or she will maintain a diversion control plan and obtain written consent from each patient regarding available treatment options. </p> <p>HHS must update the treatment improvement protocol containing best practice guidelines for the treatment of opioid-dependent patients in office-based settings. </p> <p>HHS may recommend revoking or suspending the registration of a practitioner who fails to comply with the requirements of this Act.</p>]]></text>
          <actionDesc>Reported to House amended, Part I</actionDesc>
          <updateDate>2016-05-10T14:29:42Z</updateDate>
          <lastSummaryUpdateDate>2016-06-07T17:08:51Z</lastSummaryUpdateDate>
          <actionDate>2016-05-10</actionDate>
          <versionCode>18</versionCode>
          <name>Reported to House amended, Part I</name>
        </item>
        <item>
          <text><![CDATA[<p><b>Opioid Use Disorder Treatment Expansion and Modernization Act</b></p> <p>(Sec. 3) This bill amends the Controlled Substances Act to revise the requirements for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.</p> <p>Currently, a practitioner must notify the Department of Health and Human Services (HHS) and certify that he or she is a qualifying physician (i.e., a state-licensed physician with certain expertise), has the capacity to refer patients for appropriate counseling and ancillary services, and will comply with a patient limit. The patient limit is how many patients the practitioner can treat under the office-based treatment program at one time.</p> <p>This legislation expands qualifying practitioners to include nurse practitioners and physician assistants who are licensed in a state, have expertise (such as relevant training or expertise), and prescribe medications for opioid use disorder in collaboration with or under the supervision of a qualifying physician if state law requires physician oversight of prescribing authority.</p> <p>Additionally, it requires a qualifying practitioner to also certify that he or she will comply with reporting requirements and has the capacity to provide directly or by referral, or in another manner prescribed by HHS, all drugs approved by the Food and Drug Administration to treat opioid use disorder.</p> <p>HHS may issue regulations to change the maximum patient limit for a qualifying practitioner. If HHS increases the limit, then a qualifying practitioner must additionally certify that he or she will obtain written consent from each patient regarding available treatment options.</p> <p>HHS must update the treatment improvement protocol containing best practice guidelines for the treatment of opioid-dependent patients in office-based settings.</p> <p>HHS may recommend revoking or suspending the registration of a practitioner who fails to comply with the requirements of this Act.</p> <p>(Sec. 4) The bill expresses the sense of Congress that HHS should consider raising from 100 to 250 the maximum patient limit for a qualifying physician.</p> <p>(Sec. 5) It amends the Controlled Substances Act to allow a pharmacist to partially fill a prescription for a schedule II controlled substance (such as a prescription opioid painkiller) if: (1) it is not prohibited by state law, (2) it is prescribed in accordance with existing laws and regulations, (3) it is requested by the patient or prescribing practitioner, and (4) the total quantity dispensed in partial fillings does not exceed the total quantity prescribed.</p> <p>Additionally, a pharmacist may partially fill a prescription for a schedule II controlled substance in other circumstances in accordance with existing Drug Enforcement Administration (DEA) regulations. (Current DEA regulations permit partial fills when a pharmacist cannot supply a full quantity, a patient resides in a long-term care facility, or a patient is terminally ill.)</p> <p>The remaining of a partially filled prescription may be filled within 30 days or, in the case of an emergency situation, within 72 hours.</p>]]></text>
          <actionDesc>Passed House amended</actionDesc>
          <updateDate>2016-05-11T13:40:09Z</updateDate>
          <lastSummaryUpdateDate>2016-07-07T15:46:55Z</lastSummaryUpdateDate>
          <actionDate>2016-05-11</actionDate>
          <versionCode>36</versionCode>
          <name>Passed House amended</name>
        </item>
      </billSummaries>
    </summaries>
    <relatedBills>
      <item>
        <latestTitle>Reducing Unused Medications Act of 2016</latestTitle>
        <type>HR</type>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <number>4599</number>
        <latestAction>
          <actionDate>2016-05-12</actionDate>
          <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
      </item>
      <item>
        <latestTitle>Comprehensive Addiction and Recovery Act of 2016</latestTitle>
        <type>S</type>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
          <item>
            <type>Related bill</type>
            <identifiedBy>House</identifiedBy>
          </item>
        </relationshipDetails>
        <number>524</number>
        <latestAction>
          <actionDate>2016-07-22</actionDate>
          <text>Became Public Law No: 114-198.</text>
        </latestAction>
      </item>
      <item>
        <latestTitle>Opioid Abuse Crisis Act of 2016</latestTitle>
        <type>HR</type>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <number>5189</number>
        <latestAction>
          <actionDate>2016-06-07</actionDate>
          <text>Referred to the Subcommittee on Military Personnel.</text>
        </latestAction>
      </item>
    </relatedBills>
    <billType>HR</billType>
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <systemCode>sshr00</systemCode>
          <type>Standing</type>
          <chamber>Senate</chamber>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2016-05-12T18:45:24Z</date>
            </item>
          </activities>
        </item>
        <item>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2016-04-20T13:30:41Z</date>
                </item>
              </activities>
              <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
              <systemCode>hsju08</systemCode>
            </item>
          </subcommittees>
          <systemCode>hsju00</systemCode>
          <type>Standing</type>
          <chamber>House</chamber>
          <name>Judiciary Committee</name>
          <activities>
            <item>
              <name>Discharged from</name>
              <date>2016-05-11T01:25:33Z</date>
            </item>
            <item>
              <name>Referred to</name>
              <date>2016-04-18T16:02:00Z</date>
            </item>
          </activities>
        </item>
        <item>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2016-04-22T18:26:20Z</date>
                </item>
              </activities>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <systemCode>hsif00</systemCode>
          <type>Standing</type>
          <chamber>House</chamber>
          <name>Energy and Commerce Committee</name>
          <activities>
            <item>
              <name>Reported by</name>
              <date>2016-05-11T01:25:21Z</date>
            </item>
            <item>
              <name>Markup by</name>
              <date>2016-04-27T19:49:43Z</date>
            </item>
            <item>
              <name>Referred to</name>
              <date>2016-04-18T16:01:50Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 114-561</citation>
      </committeeReport>
    </committeeReports>
    <updateDate>2017-10-27T18:04:51Z</updateDate>
    <congress>114</congress>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Medical education</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <notes />
    <createDate>2016-04-19T05:11:32Z</createDate>
    <sponsors>
      <item>
        <fullName>Rep. Bucshon, Larry [R-IN-8]</fullName>
        <state>IN</state>
        <byRequestType />
        <party>R</party>
        <lastName>Bucshon</lastName>
        <firstName>Larry</firstName>
        <bioguideId>B001275</bioguideId>
        <middleName />
        <identifiers>
          <bioguideId>B001275</bioguideId>
          <gpoId>7947</gpoId>
          <lisID>2018</lisID>
        </identifiers>
        <district>8</district>
      </item>
    </sponsors>
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

